<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="Clinical Characteristics and Predictors of Mortality in Critically Ill Influenza" exact="Adult" post="Patients HsuJui-Chi1LeeIng-Kit12*HuangWen-Chi1ChenYi-Chun1TsaiChing-Yen1[1], b9602048@cgmh.org.twheteyland@cgmh.org.twsonice83@cgmh.org.twgreenswallow822@yahoo.com.tw[2], *Correspondence: leee@cgmh.org.tw epub: 2020-4-4collection: 2020-4941073received: 2020-3-07accepted:"/>
 <result pre="of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract" exact="Severe" post="influenza is associated with high morbidity and mortality. The"/>
 <result pre="influenza patients. In this retrospective study, we enrolled critically ill" exact="adult" post="patients with influenza at the Kaohsiung Chang Gung Memorial"/>
 <result pre="illness. Of the 102 patients, the major influenza-associated complications were" exact="respiratory" post="failure (97%), pneumonia (94.1%), acute kidney injury (65.7%), adult"/>
 <result pre="102 patients, the major influenza-associated complications were respiratory failure (97%)," exact="pneumonia" post="(94.1%), acute kidney injury (65.7%), adult respiratory distress syndrome"/>
 <result pre="the major influenza-associated complications were respiratory failure (97%), pneumonia (94.1%)," exact="acute" post="kidney injury (65.7%), adult respiratory distress syndrome (ARDS) (51%),"/>
 <result pre="major influenza-associated complications were respiratory failure (97%), pneumonia (94.1%), acute" exact="kidney injury" post="(65.7%), adult respiratory distress syndrome (ARDS) (51%), gastrointestinal bleeding"/>
 <result pre="were respiratory failure (97%), pneumonia (94.1%), acute kidney injury (65.7%)," exact="adult" post="respiratory distress syndrome (ARDS) (51%), gastrointestinal bleeding (35.3%), and"/>
 <result pre="respiratory failure (97%), pneumonia (94.1%), acute kidney injury (65.7%), adult" exact="respiratory" post="distress syndrome (ARDS) (51%), gastrointestinal bleeding (35.3%), and bacteremia"/>
 <result pre="(97%), pneumonia (94.1%), acute kidney injury (65.7%), adult respiratory distress" exact="syndrome" post="(ARDS) (51%), gastrointestinal bleeding (35.3%), and bacteremia (16.7%). In"/>
 <result pre="kidney injury (65.7%), adult respiratory distress syndrome (ARDS) (51%), gastrointestinal" exact="bleeding" post="(35.3%), and bacteremia (16.7%). In the multivariate regression model,"/>
 <result pre="(16.7%). In the multivariate regression model, high lactate levels, ARDS," exact="acute" post="kidney injury, and gastrointestinal bleeding were independent predictors of"/>
 <result pre="In the multivariate regression model, high lactate levels, ARDS, acute" exact="kidney injury," post="and gastrointestinal bleeding were independent predictors of mortality in"/>
 <result pre="model, high lactate levels, ARDS, acute kidney injury, and gastrointestinal" exact="bleeding" post="were independent predictors of mortality in critically ill influenza"/>
 <result pre="that might be useful in determining patient outcomes. severe influenza" exact="pneumonia" post="acute respiratory distress syndrome lactate mortality 1. Introduction Influenza"/>
 <result pre="might be useful in determining patient outcomes. severe influenza pneumonia" exact="acute respiratory distress syndrome" post="lactate mortality 1. Introduction Influenza is an acute viral"/>
 <result pre="be useful in determining patient outcomes. severe influenza pneumonia acute" exact="respiratory" post="distress syndrome lactate mortality 1. Introduction Influenza is an"/>
 <result pre="in determining patient outcomes. severe influenza pneumonia acute respiratory distress" exact="syndrome" post="lactate mortality 1. Introduction Influenza is an acute viral"/>
 <result pre="respiratory distress syndrome lactate mortality 1. Introduction Influenza is an" exact="acute" post="viral respiratory infection caused by different types of influenza"/>
 <result pre="distress syndrome lactate mortality 1. Introduction Influenza is an acute" exact="viral" post="respiratory infection caused by different types of influenza viruses:"/>
 <result pre="syndrome lactate mortality 1. Introduction Influenza is an acute viral" exact="respiratory" post="infection caused by different types of influenza viruses: influenza"/>
 <result pre="lactate mortality 1. Introduction Influenza is an acute viral respiratory" exact="infection" post="caused by different types of influenza viruses: influenza A,"/>
 <result pre="characterized by a sudden onset of fever, cough, sore throat," exact="runny nose," post="headache, myalgia, and malaise [1]. However, the virus can"/>
 <result pre="such as young children, the elderly, patients with certain comorbid" exact="chronic" post="diseases, and immunocompromised patients [2,3]. Annually, the World Health"/>
 <result pre="deaths in the United States due to pdm09 A/H1 [7]." exact="Severe" post="complicated influenza has a significantly high mortality and morbidity"/>
 <result pre="complicated influenza has a significantly high mortality and morbidity [8,9]." exact="Secondary" post="bacterial pneumonia and acute respiratory distress syndrome (ARDS) are"/>
 <result pre="influenza has a significantly high mortality and morbidity [8,9]. Secondary" exact="bacterial" post="pneumonia and acute respiratory distress syndrome (ARDS) are some"/>
 <result pre="has a significantly high mortality and morbidity [8,9]. Secondary bacterial" exact="pneumonia" post="and acute respiratory distress syndrome (ARDS) are some of"/>
 <result pre="significantly high mortality and morbidity [8,9]. Secondary bacterial pneumonia and" exact="acute respiratory distress syndrome" post="(ARDS) are some of the common pulmonary complications of"/>
 <result pre="high mortality and morbidity [8,9]. Secondary bacterial pneumonia and acute" exact="respiratory" post="distress syndrome (ARDS) are some of the common pulmonary"/>
 <result pre="and morbidity [8,9]. Secondary bacterial pneumonia and acute respiratory distress" exact="syndrome" post="(ARDS) are some of the common pulmonary complications of"/>
 <result pre="acute respiratory distress syndrome (ARDS) are some of the common" exact="pulmonary" post="complications of influenza, often followed by grave outcomes [10]."/>
 <result pre="influenza, often followed by grave outcomes [10]. In addition to" exact="pulmonary" post="complications, extra-pulmonary complications such as meningoencephalitis, myocarditis, and rhabdomyolysis"/>
 <result pre="to pulmonary complications, extra-pulmonary complications such as meningoencephalitis, myocarditis, and" exact="rhabdomyolysis" post="have also been reported to be associated with either"/>
 <result pre="Study Design and Patients We retrospectively studied all critically ill" exact="adult" post="patients (aged ≥18 years) with laboratory-confirmed influenza infection admitted"/>
 <result pre="critically ill adult patients (aged ≥18 years) with laboratory-confirmed influenza" exact="infection" post="admitted between 2015 and 2018, at the Kaohsiung Chang"/>
 <result pre="2018, at the Kaohsiung Chang Gung Memorial Hospital, a 2700-bed" exact="primary" post="care and tertiary referral medical center that included 5"/>
 <result pre="primary care and tertiary referral medical center that included 5" exact="adult" post="medical and 4 surgical intensive care units (ICUs) in"/>
 <result pre="those admitted to an ICU, or those with complications of" exact="lower" post="respiratory tract infection and/or multiorgan failure, or those requiring"/>
 <result pre="admitted to an ICU, or those with complications of lower" exact="respiratory" post="tract infection and/or multiorgan failure, or those requiring mechanical"/>
 <result pre="an ICU, or those with complications of lower respiratory tract" exact="infection" post="and/or multiorgan failure, or those requiring mechanical ventilation during"/>
 <result pre="or if they had mild flu-like symptoms. Confirmation of influenza" exact="virus infection" post="required a positive finding in the respiratory specimen (nasopharyngeal"/>
 <result pre="if they had mild flu-like symptoms. Confirmation of influenza virus" exact="infection" post="required a positive finding in the respiratory specimen (nasopharyngeal"/>
 <result pre="of influenza virus infection required a positive finding in the" exact="respiratory" post="specimen (nasopharyngeal swab and/or pharyngeal swab) by one or"/>
 <result pre="kidney (MDCK) cell line), or reverse-transcriptase–polymerase chain reaction (RT-PCR) (QiAamp" exact="Viral" post="RNA Mini Kit; TAIGEN Bioscience Corporation, Taiwan). The choice"/>
 <result pre="the hospital’s electronic medical records and were supplemented by a" exact="secondary" post="manual search. The following data were collected: demographic characteristics,"/>
 <result pre="and during the entire clinical course, in-hospital complications, and fatality." exact="Acute" post="respiratory failure was defined as arterial partial pressure of"/>
 <result pre="during the entire clinical course, in-hospital complications, and fatality. Acute" exact="respiratory" post="failure was defined as arterial partial pressure of oxygen"/>
 <result pre="complications, and fatality. Acute respiratory failure was defined as arterial" exact="partial" post="pressure of oxygen (PaO2) &amp;lt;60 mmHg in ambient air,"/>
 <result pre="in ambient air, or tachypnea &amp;gt;30/min. ARDS was defined as" exact="acute" post="respiratory distress characterized by bilateral pulmonary consolidation and severe"/>
 <result pre="ambient air, or tachypnea &amp;gt;30/min. ARDS was defined as acute" exact="respiratory" post="distress characterized by bilateral pulmonary consolidation and severe hypoxemia"/>
 <result pre="&amp;gt;30/min. ARDS was defined as acute respiratory distress characterized by" exact="bilateral" post="pulmonary consolidation and severe hypoxemia (PaO2/Fraction of inspired oxygen"/>
 <result pre="ARDS was defined as acute respiratory distress characterized by bilateral" exact="pulmonary" post="consolidation and severe hypoxemia (PaO2/Fraction of inspired oxygen ratio"/>
 <result pre="hypoxemia (PaO2/Fraction of inspired oxygen ratio &amp;lt;300 mmHg) in the" exact="absence of" post="evidence for cardiogenic pulmonary edema [17]. Fulminant hepatitis meant"/>
 <result pre="ratio &amp;lt;300 mmHg) in the absence of evidence for cardiogenic" exact="pulmonary edema" post="[17]. Fulminant hepatitis meant alanine aminotransferase levels (ALT) greater"/>
 <result pre="the absence of evidence for cardiogenic pulmonary edema [17]. Fulminant" exact="hepatitis" post="meant alanine aminotransferase levels (ALT) greater than 16.6 µkat/L."/>
 <result pre="hepatitis meant alanine aminotransferase levels (ALT) greater than 16.6 µkat/L." exact="Acute" post="kidney injury was defined as a rapid increase in"/>
 <result pre="meant alanine aminotransferase levels (ALT) greater than 16.6 µkat/L. Acute" exact="kidney injury" post="was defined as a rapid increase in the serum"/>
 <result pre="defined as a five-fold increase in the serum concentrations of" exact="creatine phosphokinase" post="above the upper limit of the normal range (reference"/>
 <result pre="increase in the serum concentrations of creatine phosphokinase above the" exact="upper" post="limit of the normal range (reference value, 0.2–2.2 µkat/L),"/>
 <result pre="range (reference value, 0.2–2.2 µkat/L), with &amp;gt;95% creatine phosphokinase-muscle fraction." exact="Meningoencephalitis" post="was defined as an altered mental status, fulfilling at"/>
 <result pre="2 of the following criteria: (1) fever, (2) seizure, (3)" exact="focal" post="neurologic signs, (4) abnormality of cerebrospinal fluid, (5) neuroimaging"/>
 <result pre="of encephalitis, and (6) abnormal findings on electroencephalography consistent with" exact="encephalitis" post="[18]. A galactomannan cutoff optical density index of &amp;gt;0.5"/>
 <result pre="to select cutoff points for independent numerical predictors according to" exact="visual" post="assessment of the highest sensitivity and specificity. We then"/>
 <result pre="with a median age of 62 years with laboratory-confirmed influenza" exact="virus infection" post="were assessed. The median time from illness onset to"/>
 <result pre="a median age of 62 years with laboratory-confirmed influenza virus" exact="infection" post="were assessed. The median time from illness onset to"/>
 <result pre="during the entire clinical course. The five common complications were" exact="respiratory" post="failure (97%), pneumonia (94.1%), acute kidney injury (65.7%), ARDS"/>
 <result pre="clinical course. The five common complications were respiratory failure (97%)," exact="pneumonia" post="(94.1%), acute kidney injury (65.7%), ARDS (51%), and gastrointestinal"/>
 <result pre="The five common complications were respiratory failure (97%), pneumonia (94.1%)," exact="acute" post="kidney injury (65.7%), ARDS (51%), and gastrointestinal bleeding (35.3%)."/>
 <result pre="five common complications were respiratory failure (97%), pneumonia (94.1%), acute" exact="kidney injury" post="(65.7%), ARDS (51%), and gastrointestinal bleeding (35.3%). Of 59"/>
 <result pre="pneumonia (94.1%), acute kidney injury (65.7%), ARDS (51%), and gastrointestinal" exact="bleeding" post="(35.3%). Of 59 patients with data available, the median"/>
 <result pre="Of 59 patients with data available, the median Sequential Organ" exact="Failure" post="Assessment score was 6 (range, 2–16). All of the"/>
 <result pre="12 (11.7%) noninvasively. The median time from illness onset to" exact="acute" post="respiratory failure was four days (range, 1–27). Inotropes or"/>
 <result pre="(11.7%) noninvasively. The median time from illness onset to acute" exact="respiratory" post="failure was four days (range, 1–27). Inotropes or vasopressors"/>
 <result pre="had influenza A virus and 2 (11.7%) had influenza B" exact="virus infection." post="The median duration of ECMO support was nine (range,"/>
 <result pre="treatment, 12 (70.5%) died. In the 12 patients who died," exact="acute" post="kidney injury (n = 10), gastrointestinal bleeding (n ="/>
 <result pre="12 (70.5%) died. In the 12 patients who died, acute" exact="kidney injury" post="(n = 10), gastrointestinal bleeding (n = 8), rhabdomyolysis"/>
 <result pre="patients who died, acute kidney injury (n = 10), gastrointestinal" exact="bleeding" post="(n = 8), rhabdomyolysis (n = 4), pneumothorax (n"/>
 <result pre="kidney injury (n = 10), gastrointestinal bleeding (n = 8)," exact="rhabdomyolysis" post="(n = 4), pneumothorax (n = 2), intracranial hemorrhage"/>
 <result pre="10), gastrointestinal bleeding (n = 8), rhabdomyolysis (n = 4)," exact="pneumothorax" post="(n = 2), intracranial hemorrhage (n = 1), and"/>
 <result pre="(n = 2), intracranial hemorrhage (n = 1), and fulminant" exact="hepatitis" post="(n = 1) were the most common conditions contributing"/>
 <result pre="maltophilia (n = 2), viridans streptococcus (n = 1), and" exact="Acinetobacter" post="pittii (n = 1). Staphylococcus aureus (35.3%) (16.7% were"/>
 <result pre="80.5% had influenza A virus and 19.5% had influenza B" exact="virus infection." post="Of the 38 deceased patients who received oseltamivir treatment,"/>
 <result pre="of the illness (Table 4). Among the 41 deceased patients," exact="pneumonia" post="developed in 39 (95.1%) patients, acute kidney injury in"/>
 <result pre="the 41 deceased patients, pneumonia developed in 39 (95.1%) patients," exact="acute" post="kidney injury in 33 (80.5%), ARDS in 27 (65.9%),"/>
 <result pre="41 deceased patients, pneumonia developed in 39 (95.1%) patients, acute" exact="kidney injury" post="in 33 (80.5%), ARDS in 27 (65.9%), gastrointestinal bleeding"/>
 <result pre="kidney injury in 33 (80.5%), ARDS in 27 (65.9%), gastrointestinal" exact="bleeding" post="in 21 (51.2%), and bacteremia in 6 (35.3%) patients"/>
 <result pre="myoglobin, creatine kinase–MB isoenzyme, and lactate concentrations, in addition to" exact="lower" post="platelet count during the course of hospitalization, were reported"/>
 <result pre="received ECMO treatment and had a significantly higher incidence of" exact="acute" post="kidney injury, pneumothorax, ARDS, and gastrointestinal bleeding than survivors."/>
 <result pre="ECMO treatment and had a significantly higher incidence of acute" exact="kidney injury," post="pneumothorax, ARDS, and gastrointestinal bleeding than survivors. Multivariate analysis"/>
 <result pre="higher incidence of acute kidney injury, pneumothorax, ARDS, and gastrointestinal" exact="bleeding" post="than survivors. Multivariate analysis showed that high lactate level"/>
 <result pre="0.001), ARDS (aOR: 10.098; 95% CI: 2.505–40.714; p = 0.001)," exact="acute" post="kidney injury (aOR: 9.019; 95% CI: 1.804–45.089; p ="/>
 <result pre="ARDS (aOR: 10.098; 95% CI: 2.505–40.714; p = 0.001), acute" exact="kidney injury" post="(aOR: 9.019; 95% CI: 1.804–45.089; p = 0.007), and"/>
 <result pre="(aOR: 9.019; 95% CI: 1.804–45.089; p = 0.007), and gastrointestinal" exact="bleeding" post="(aOR: 3.828; 95% CI: 1.180–12.415; p = 0.025) were"/>
 <result pre="(p &amp;lt; 0.001). 4. Discussion In a study involving 444" exact="adult" post="patients with influenza in hospitals in the United States,"/>
 <result pre="their study of 2059 patients admitted to ICUs for influenza" exact="infection" post="[22]. In our study, a mortality rate as high"/>
 <result pre="as high as 40% was found in 102 critically ill" exact="adult" post="patients with influenza. However, which variables can predict poor"/>
 <result pre="However, which variables can predict poor patient outcomes after influenza" exact="virus infection" post="remain to be elucidated. In the present study, our"/>
 <result pre="which variables can predict poor patient outcomes after influenza virus" exact="infection" post="remain to be elucidated. In the present study, our"/>
 <result pre="results underscore that high blood lactate levels during hospitalization, ARDS," exact="acute" post="kidney injury, and gastrointestinal bleeding were independent risk factors"/>
 <result pre="underscore that high blood lactate levels during hospitalization, ARDS, acute" exact="kidney injury," post="and gastrointestinal bleeding were independent risk factors of mortality"/>
 <result pre="lactate levels during hospitalization, ARDS, acute kidney injury, and gastrointestinal" exact="bleeding" post="were independent risk factors of mortality in critically ill"/>
 <result pre="critically ill influenza patients. High blood lactate levels indicate tissue" exact="hypoxia" post="due to increased lactate generation via anaerobic glycolysis [23]."/>
 <result pre="levels have been correlated with poor outcomes in patients with" exact="bacterial" post="sepsis and septic shock [24]. In the present study,"/>
 <result pre="correlated with poor outcomes in patients with bacterial sepsis and" exact="septic shock" post="[24]. In the present study, high blood lactate levels"/>
 <result pre="patients. In addition, nonsurvivors had a significantly higher prevalence of" exact="acute" post="kidney injury and gastrointestinal bleeding and received ECMO treatment"/>
 <result pre="In addition, nonsurvivors had a significantly higher prevalence of acute" exact="kidney injury" post="and gastrointestinal bleeding and received ECMO treatment in our"/>
 <result pre="a significantly higher prevalence of acute kidney injury and gastrointestinal" exact="bleeding" post="and received ECMO treatment in our series. Importantly, acute"/>
 <result pre="gastrointestinal bleeding and received ECMO treatment in our series. Importantly," exact="acute" post="kidney injury and gastrointestinal bleeding have been shown to"/>
 <result pre="bleeding and received ECMO treatment in our series. Importantly, acute" exact="kidney injury" post="and gastrointestinal bleeding have been shown to be independent"/>
 <result pre="treatment in our series. Importantly, acute kidney injury and gastrointestinal" exact="bleeding" post="have been shown to be independent risk factors of"/>
 <result pre="hypoperfusion and initiation of effective volume replacement to reverse tissue" exact="hypoxia" post="are critical steps in preventing mortality and morbidity. Notably,"/>
 <result pre="in critically ill influenza patients. Our series here showed gastrointestinal" exact="bleeding" post="occurred in one-third of included patients and more than"/>
 <result pre="not universally practiced in our series. The causes of gastrointestinal" exact="bleeding" post="in these patients are multifactorial. Our study underlines that"/>
 <result pre="study underlines that clinicians should be alert to possible gastrointestinal" exact="bleeding" post="when caring for a critically ill influenza patient because"/>
 <result pre="and treated accordingly. ARDS is a lethal complication of influenza" exact="infection" post="[25]. Ortiz et al. estimated that the incidence of"/>
 <result pre="[25]. Ortiz et al. estimated that the incidence of influenza-associated" exact="acute" post="respiratory failure was 2.7 events per 100,000 person–years [26]."/>
 <result pre="Ortiz et al. estimated that the incidence of influenza-associated acute" exact="respiratory" post="failure was 2.7 events per 100,000 person–years [26]. In"/>
 <result pre="58 patients with ARDS, 28 (48.2%) were due to influenza" exact="virus infection," post="and 32.1% of the patients with influenza-associated ARDS received"/>
 <result pre="previous findings wherein 97% of critically ill influenza patients developed" exact="acute" post="respiratory failure with a median time of four days"/>
 <result pre="findings wherein 97% of critically ill influenza patients developed acute" exact="respiratory" post="failure with a median time of four days between"/>
 <result pre="a median time of four days between illness onset and" exact="respiratory" post="failure, and 51% of them subsequently developed ARDS during"/>
 <result pre="the patients with influenza-associated ARDS required ECMO for profound hypoxemic" exact="respiratory" post="failure. Our study highlights that severe oxygenation failure occurred"/>
 <result pre="lactate might be of greater value than others when allocating" exact="limited" post="healthcare resources. Previous studies have shown that early administration"/>
 <result pre="In our study, bacteremia was detected in 17 critically ill" exact="adult" post="patients. Importantly, five of them acquired bacteremia within 48"/>
 <result pre="in 17 critically ill adult patients. Importantly, five of them" exact="acquired" post="bacteremia within 48 h after hospitalization, and in three"/>
 <result pre="within 48 h after hospitalization, and in three cases, the" exact="infection" post="was caused by Staphylococcus aureus. A report of the"/>
 <result pre="In a study of 32 influenza-positive patients (including pediatric and" exact="adult" post="patients), poor outcomes were found among patients who were"/>
 <result pre="underscore that Staphylococcus aureus remains the most important cause of" exact="bacterial" post="coinfection in pediatric and adult influenza patients. Invasive pulmonary"/>
 <result pre="the most important cause of bacterial coinfection in pediatric and" exact="adult" post="influenza patients. Invasive pulmonary Aspergillus as a coinfection in"/>
 <result pre="cause of bacterial coinfection in pediatric and adult influenza patients." exact="Invasive" post="pulmonary Aspergillus as a coinfection in patients with severe"/>
 <result pre="of bacterial coinfection in pediatric and adult influenza patients. Invasive" exact="pulmonary" post="Aspergillus as a coinfection in patients with severe influenza"/>
 <result pre="and the use of corticosteroids were independent risk factors for" exact="invasive aspergillosis" post="[35]. In the present study, invasive pulmonary aspergillosis was"/>
 <result pre="the use of corticosteroids were independent risk factors for invasive" exact="aspergillosis" post="[35]. In the present study, invasive pulmonary aspergillosis was"/>
 <result pre="risk factors for invasive aspergillosis [35]. In the present study," exact="invasive pulmonary aspergillosis" post="was confirmed in two deceased influenza patients with high"/>
 <result pre="factors for invasive aspergillosis [35]. In the present study, invasive" exact="pulmonary" post="aspergillosis was confirmed in two deceased influenza patients with"/>
 <result pre="for invasive aspergillosis [35]. In the present study, invasive pulmonary" exact="aspergillosis" post="was confirmed in two deceased influenza patients with high"/>
 <result pre="emphasizes that clinicians should be aware of the risk of" exact="invasive aspergillosis" post="in critically ill influenza patients, particularly immunocompromised patients or"/>
 <result pre="that clinicians should be aware of the risk of invasive" exact="aspergillosis" post="in critically ill influenza patients, particularly immunocompromised patients or"/>
 <result pre="to understand the incidence, risk factors, and clinical features of" exact="invasive pulmonary aspergillosis" post="in influenza patients. In 2003, an avian influenza virus"/>
 <result pre="understand the incidence, risk factors, and clinical features of invasive" exact="pulmonary" post="aspergillosis in influenza patients. In 2003, an avian influenza"/>
 <result pre="the incidence, risk factors, and clinical features of invasive pulmonary" exact="aspergillosis" post="in influenza patients. In 2003, an avian influenza virus"/>
 <result pre="of invasive pulmonary aspergillosis in influenza patients. In 2003, an" exact="avian influenza" post="virus of H5N1 subtype was isolated from a smuggled"/>
 <result pre="duck in Kinmen Island of Taiwan [38]. However, no locally" exact="acquired" post="H5N1 disease in humans had been reported in Taiwan"/>
 <result pre="Kinmen Island of Taiwan [38]. However, no locally acquired H5N1" exact="disease" post="in humans had been reported in Taiwan [39]. Thus,"/>
 <result pre="pneumococcus and influenza, and some missing laboratory data such as" exact="pneumonia" post="severity index and coagulation profile, were not collected. Second,"/>
 <result pre="coagulation profile, were not collected. Second, the study population comprised" exact="adult" post="patients; therefore, the results cannot be generalized to pediatric"/>
 <result pre="in the selection of the main key clinical data in" exact="primary" post="care at the initial clinical evaluation of critically ill"/>
 <result pre="1.NicholsonK.G.WoodJ.M.ZambonM.InfluenzaLancet20033621733174510.1016/S0140-6736(03)14854-414643124 2.ThompsonW.W.ShayD.K.WeintraubE.BrammerL.BridgesC.B.CoxN.J.FukudaK.Influenza-associated hospitalizations in the United StatesJAMA20042921333134010.1001/jama.292.11.133315367555 3.collab: Centers for" exact="Disease" post="Control and Prevention (CDC)Estimates of deaths associated with seasonal"/>
 <result pre="on 12 January 2020) 5.IulianoA.D.RoguskiK.M.ChangH.H.MuscatelloD.J.PalekarR.TempiaS.CohenC.GranJ.M.SchanzerD.CowlingB.J.et al.Estimates of global seasonal influenza-associated" exact="respiratory" post="mortality: A modelling studyLancet20183911285130010.1016/S0140-6736(17)33293-229248255 6.DawoodF.S.JainS.FinelliL.ShawM.W.LindstromS.GartenR.J.GubarevaL.V.XuX.BridgesC.B.UyekiT.M.Novel Swine-Origin Influenza A (H1N1)"/>
 <result pre="global seasonal influenza-associated respiratory mortality: A modelling studyLancet20183911285130010.1016/S0140-6736(17)33293-229248255 6.DawoodF.S.JainS.FinelliL.ShawM.W.LindstromS.GartenR.J.GubarevaL.V.XuX.BridgesC.B.UyekiT.M.Novel Swine-Origin" exact="Influenza A (H1N1)" post="Virus Investigation Team. Emergence of a novel swine origin"/>
 <result pre="United States (April 2009–April 2010)Clin. Infect. Dis.201152S75S8210.1093/cid/ciq01221342903 8.ZhouF.LiH.GuL.LiuM.XueC.X.CaoB.WangC.Risk factors for" exact="nosocomial infection" post="among hospitalised severe influenza A(H1N1)pdm09 patientsRespir. Med.2018134869110.1016/j.rmed.2017.11.01729413513 9.PaddockC.D.LiuL.DenisonA.M.BartlettJ.H.HolmanR.C.Deleon-CarnersM.EmeryS.L.DrewC.P.ShiehW.J.UyekiT.M.Myocardial injury"/>
 <result pre="States (April 2009–April 2010)Clin. Infect. Dis.201152S75S8210.1093/cid/ciq01221342903 8.ZhouF.LiH.GuL.LiuM.XueC.X.CaoB.WangC.Risk factors for nosocomial" exact="infection" post="among hospitalised severe influenza A(H1N1)pdm09 patientsRespir. Med.2018134869110.1016/j.rmed.2017.11.01729413513 9.PaddockC.D.LiuL.DenisonA.M.BartlettJ.H.HolmanR.C.Deleon-CarnersM.EmeryS.L.DrewC.P.ShiehW.J.UyekiT.M.Myocardial injury"/>
 <result pre="among hospitalised severe influenza A(H1N1)pdm09 patientsRespir. Med.2018134869110.1016/j.rmed.2017.11.01729413513 9.PaddockC.D.LiuL.DenisonA.M.BartlettJ.H.HolmanR.C.Deleon-CarnersM.EmeryS.L.DrewC.P.ShiehW.J.UyekiT.M.Myocardial injury and" exact="bacterial" post="pneumonia contribute to the pathogenesis of fatal influenza B"/>
 <result pre="hospitalised severe influenza A(H1N1)pdm09 patientsRespir. Med.2018134869110.1016/j.rmed.2017.11.01729413513 9.PaddockC.D.LiuL.DenisonA.M.BartlettJ.H.HolmanR.C.Deleon-CarnersM.EmeryS.L.DrewC.P.ShiehW.J.UyekiT.M.Myocardial injury and bacterial" exact="pneumonia" post="contribute to the pathogenesis of fatal influenza B virus"/>
 <result pre="H1N1 Collaborative. Critically ill patients with 2009 influenza A (H1N1)" exact="infection" post="in CanadaJAMA20093021872187910.1001/jama.2009.149619822627 12.RelloJ.RodríguezA.IbañezP.SociasL.CebrianJ.MarquesA.GuerreroJ.Ruiz-SantanaS.MarquezE.Nogel-SaezF.D.H1N1 SEMICYUC Working Group. Intensive care adult"/>
 <result pre="(H1N1) infection in CanadaJAMA20093021872187910.1001/jama.2009.149619822627 12.RelloJ.RodríguezA.IbañezP.SociasL.CebrianJ.MarquesA.GuerreroJ.Ruiz-SantanaS.MarquezE.Nogel-SaezF.D.H1N1 SEMICYUC Working Group. Intensive care" exact="adult" post="patients with severe respiratory failure caused by Influenza A"/>
 <result pre="12.RelloJ.RodríguezA.IbañezP.SociasL.CebrianJ.MarquesA.GuerreroJ.Ruiz-SantanaS.MarquezE.Nogel-SaezF.D.H1N1 SEMICYUC Working Group. Intensive care adult patients with severe" exact="respiratory" post="failure caused by Influenza A (H1N1)v in SpainCrit. Care200913R14810.1186/cc804419747383"/>
 <result pre="randomised placebo-controlled trialLancet Infect. Dis.20141410911810.1016/S1473-3099(13)70267-624268590 17.collab: ARDS Definition Task ForceRanieriV.M.RubenfeldG.D.ThompsonB.T.FergusonN.D.CaldwellE.FanE.CamporotaL.SlutskyA.S.Acute" exact="Respiratory" post="Distress SyndromeJAMA20123072526253310.1001/jama.2012.566922797452 18.SteinerI.BudkaH.ChaudhuriA.KoskiniemiM.SainioK.SalonenO.KennedyP.G.Viral meningoencephalitis: A review of diagnostic methods"/>
 <result pre="managementEur. J. Neurol.201017e5710.1111/j.1468-1331.2010.02970.x 19.HeerK.D.GerritsenM.G.VisserC.E.LeeflangM.M.Galactomannan detection in broncho-alveolar lavage fluid for" exact="invasive aspergillosis" post="in immunocompromised patientsCochrane Database Syst. Rev.201910.1002/14651858.cd012399.pub2 20.MaertensJ.TheunissenK.VerbekenE.LagrouK.VerhaegenJ.BoogaertsM.EldereJ.V.Prospective clinical evaluation"/>
 <result pre="J. Neurol.201017e5710.1111/j.1468-1331.2010.02970.x 19.HeerK.D.GerritsenM.G.VisserC.E.LeeflangM.M.Galactomannan detection in broncho-alveolar lavage fluid for invasive" exact="aspergillosis" post="in immunocompromised patientsCochrane Database Syst. Rev.201910.1002/14651858.cd012399.pub2 20.MaertensJ.TheunissenK.VerbekenE.LagrouK.VerhaegenJ.BoogaertsM.EldereJ.V.Prospective clinical evaluation"/>
 <result pre="in immunocompromised patientsCochrane Database Syst. Rev.201910.1002/14651858.cd012399.pub2 20.MaertensJ.TheunissenK.VerbekenE.LagrouK.VerhaegenJ.BoogaertsM.EldereJ.V.Prospective clinical evaluation of" exact="lower" post="cut-offs for galactomannan detection in adult neutropenic cancer patients"/>
 <result pre="20.MaertensJ.TheunissenK.VerbekenE.LagrouK.VerhaegenJ.BoogaertsM.EldereJ.V.Prospective clinical evaluation of lower cut-offs for galactomannan detection in" exact="adult" post="neutropenic cancer patients and haematological stem cell transplant recipientsBr."/>
 <result pre="evaluation of lower cut-offs for galactomannan detection in adult neutropenic" exact="cancer" post="patients and haematological stem cell transplant recipientsBr. J. Haematol.200412685286010.1111/j.1365-2141.2004.05140.x15352990"/>
 <result pre="GETGAG/SEMICYUC Study Group. Delay in diagnosis of influenza A (H1N1)pdm09" exact="virus infection" post="in critically ill patients and impact on clinical outcomeCrit."/>
 <result pre="Study Group. Delay in diagnosis of influenza A (H1N1)pdm09 virus" exact="infection" post="in critically ill patients and impact on clinical outcomeCrit."/>
 <result pre="of organ failure and shockCrit. Care Med.2009371670167710.1097/CCM.0b013e31819fcf6819325467 25.ShortK.R.KroezeE.FouchierR.KuikenT.Pathogenesis of influenza-induced" exact="acute" post="respiratory distress syndromeLancet Infect. Dis.201414576910.1016/S1473-3099(13)70286-X24239327 26.OrtizJ.R.NeuzilK.M.RueT.C.ZhouH.ShayD.K.ChengP.Y.CookeC.R.GossC.H.Population-based Incidence Estimates of"/>
 <result pre="organ failure and shockCrit. Care Med.2009371670167710.1097/CCM.0b013e31819fcf6819325467 25.ShortK.R.KroezeE.FouchierR.KuikenT.Pathogenesis of influenza-induced acute" exact="respiratory" post="distress syndromeLancet Infect. Dis.201414576910.1016/S1473-3099(13)70286-X24239327 26.OrtizJ.R.NeuzilK.M.RueT.C.ZhouH.ShayD.K.ChengP.Y.CookeC.R.GossC.H.Population-based Incidence Estimates of Influenza-associated"/>
 <result pre="respiratory distress syndromeLancet Infect. Dis.201414576910.1016/S1473-3099(13)70286-X24239327 26.OrtizJ.R.NeuzilK.M.RueT.C.ZhouH.ShayD.K.ChengP.Y.CookeC.R.GossC.H.Population-based Incidence Estimates of Influenza-associated" exact="Respiratory" post="Failure Hospitalizations, 2003 to 2009Am. J. Respir. Crit. Care"/>
 <result pre="distress syndromeLancet Infect. Dis.201414576910.1016/S1473-3099(13)70286-X24239327 26.OrtizJ.R.NeuzilK.M.RueT.C.ZhouH.ShayD.K.ChengP.Y.CookeC.R.GossC.H.Population-based Incidence Estimates of Influenza-associated Respiratory" exact="Failure" post="Hospitalizations, 2003 to 2009Am. J. Respir. Crit. Care Med.201318871071510.1164/rccm.201212-2341OC23855650"/>
 <result pre="Respir. Crit. Care Med.201318871071510.1164/rccm.201212-2341OC23855650 27.YooJ.W.JuS.LeeS.J.ChoM.C.ChoY.J.JeongY.Y.LeeJ.D.KimH.C.Characteristics and Outcomes of Patients with" exact="Pulmonary" post="Acute Respiratory Distress Syndrome Infected with Influenza versus Other"/>
 <result pre="Crit. Care Med.201318871071510.1164/rccm.201212-2341OC23855650 27.YooJ.W.JuS.LeeS.J.ChoM.C.ChoY.J.JeongY.Y.LeeJ.D.KimH.C.Characteristics and Outcomes of Patients with Pulmonary" exact="Acute" post="Respiratory Distress Syndrome Infected with Influenza versus Other Respiratory"/>
 <result pre="Care Med.201318871071510.1164/rccm.201212-2341OC23855650 27.YooJ.W.JuS.LeeS.J.ChoM.C.ChoY.J.JeongY.Y.LeeJ.D.KimH.C.Characteristics and Outcomes of Patients with Pulmonary Acute" exact="Respiratory" post="Distress Syndrome Infected with Influenza versus Other Respiratory VirusesTuberc."/>
 <result pre="27.YooJ.W.JuS.LeeS.J.ChoM.C.ChoY.J.JeongY.Y.LeeJ.D.KimH.C.Characteristics and Outcomes of Patients with Pulmonary Acute Respiratory Distress" exact="Syndrome" post="Infected with Influenza versus Other Respiratory VirusesTuberc. Respir. Dis.20198232810.4046/trd.2019.0017"/>
 <result pre="Pulmonary Acute Respiratory Distress Syndrome Infected with Influenza versus Other" exact="Respiratory" post="VirusesTuberc. Respir. Dis.20198232810.4046/trd.2019.0017 28.DaviesA.JonesD.BaileyM.BecaJ.BellomoR.BlackwellN.ForrestP.GattasD.GrangerE.Extracorporeal Membrane Oxygenation for 2009 Influenza"/>
 <result pre="VirusesTuberc. Respir. Dis.20198232810.4046/trd.2019.0017 28.DaviesA.JonesD.BaileyM.BecaJ.BellomoR.BlackwellN.ForrestP.GattasD.GrangerE.Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1)" exact="Acute" post="Respiratory Distress SyndromeJAMA20093021888189510.1001/jama.2009.153519822628 29.LiG.YilmazM.KojicicM.Fernández-PérezE.WahabR.HuskinsW.C.AfessaB.TruwitJ.D.GajicO.Outcome of critically ill patients with"/>
 <result pre="Respir. Dis.20198232810.4046/trd.2019.0017 28.DaviesA.JonesD.BaileyM.BecaJ.BellomoR.BlackwellN.ForrestP.GattasD.GrangerE.Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute" exact="Respiratory" post="Distress SyndromeJAMA20093021888189510.1001/jama.2009.153519822628 29.LiG.YilmazM.KojicicM.Fernández-PérezE.WahabR.HuskinsW.C.AfessaB.TruwitJ.D.GajicO.Outcome of critically ill patients with influenza"/>
 <result pre="with influenza virus infectionJ. Clin. Virol.20094627527810.1016/j.jcv.2009.07.01519699141 30.JainS.KamimotoL.BramleyA.M.SchmitzA.M.BenoitS.R.LouieJ.SugermanD.E.DruckenmillerJ.K.RitgerK.A.ChughR.Hospitalized Patients with 2009" exact="H1N1 Influenza" post="in the United States, April–June 2009N. Engl. J. Med.20093611935194410.1056/NEJMoa090669519815859"/>
 <result pre="United States, April–June 2009N. Engl. J. Med.20093611935194410.1056/NEJMoa090669519815859 31.HanshaoworakulW.SimmermanJ.M.NarueponjirakulU.SanasuttipunW.ShindeV.KaewchanaS.AreechokechaiD.LevyJ.UngchusakK.Severe Human Influenza" exact="Infections" post="in Thailand: Oseltamivir Treatment and Risk Factors for Fatal"/>
 <result pre="and Iowa, USAEmerg. Infect. Dis.2016221253125610.3201/eid2207.15131927315549 35.SchauwvliegheA.RijndersB.PhilipsN.VerwijsR.VanderbekeL.Van TienenC.LagrouK.VerweijP.E.Van de VeerdonkF.L.GommersD.et al.Invasive" exact="aspergillosis" post="in patients admitted to the intensive care unit with"/>
 <result pre="influenza: A retrospective cohort studyLancet Respir. Med.2018678279210.1016/S2213-2600(18)30274-130076119 36.WautersJ.BaarI.MeerssemanP.MeerssemanW.DamsK.De PaepR.LagrouK.WilmerA.JorensP.HermansG.et al.Invasive" exact="pulmonary" post="aspergillosis is a frequent complication of critically ill H1N1"/>
 <result pre="A retrospective cohort studyLancet Respir. Med.2018678279210.1016/S2213-2600(18)30274-130076119 36.WautersJ.BaarI.MeerssemanP.MeerssemanW.DamsK.De PaepR.LagrouK.WilmerA.JorensP.HermansG.et al.Invasive pulmonary" exact="aspergillosis" post="is a frequent complication of critically ill H1N1 patients:"/>
 <result pre="retrospective studyIntensive Care Med.2012381761176810.1007/s00134-012-2673-222895826 37.Van de VeerdonkF.L.KolwijckE.LestradeP.P.HodiamontC.J.RijndersB.J.van PaassenJ.HaasP.J.Dos SantosC.O.KampingaG.A.BergmansD.C.et al.Influenza-associated" exact="Aspergillosis" post="in Critically Ill PatientsAm. J. Respir. Crit. Care Med.201719652452710.1164/rccm.201612-2540LE28387526"/>
 <result pre="PatientsAm. J. Respir. Crit. Care Med.201719652452710.1164/rccm.201612-2540LE28387526 38.LeeM.S.DengM.C.LinY.J.ChangC.Y.ShiehH.K.ShiauJ.Z.HuangC.C.Characterization of an H5N1" exact="avian influenza" post="virus from TaiwanVet. Microbiol.200712419320110.1016/j.vetmic.2007.04.02117512143 39.GongY.N.KuoR.L.ChenG.W.ShihS.R.Centennial review of influenza in"/>
 <result pre="19 (46.3) ≥65 year 44 (43.1) 31 (50.8) 13 (31.7)" exact="Female" post="gender, N (%) 40 (39) 23 (37.7) 17 (41.5)"/>
 <result pre="(17.8–37.8) (n = 31) 0.583 Underlying condition, N (%) Bronchial" exact="asthma" post="7 (6.9) 4 (6.6) 3 (7.3) &amp;gt;0.99 Hypertension 56"/>
 <result pre="(%) Bronchial asthma 7 (6.9) 4 (6.6) 3 (7.3) &amp;gt;0.99" exact="Hypertension" post="56 (54.9) 38 (62.3) 18 (43.9) 0.073 Type 2"/>
 <result pre="(7.3) &amp;gt;0.99 Hypertension 56 (54.9) 38 (62.3) 18 (43.9) 0.073" exact="Type 2" post="diabetes mellitus 45 (44.1) 28 (45.9) 17 (41.5) 0.689"/>
 <result pre="Hypertension 56 (54.9) 38 (62.3) 18 (43.9) 0.073 Type 2" exact="diabetes mellitus" post="45 (44.1) 28 (45.9) 17 (41.5) 0.689 Chronic kidney"/>
 <result pre="2 diabetes mellitus 45 (44.1) 28 (45.9) 17 (41.5) 0.689" exact="Chronic" post="kidney disease 16 (15.7) 13 (21.3) 3 (7.3) 0.094"/>
 <result pre="diabetes mellitus 45 (44.1) 28 (45.9) 17 (41.5) 0.689 Chronic" exact="kidney disease" post="16 (15.7) 13 (21.3) 3 (7.3) 0.094 End stage"/>
 <result pre="mellitus 45 (44.1) 28 (45.9) 17 (41.5) 0.689 Chronic kidney" exact="disease" post="16 (15.7) 13 (21.3) 3 (7.3) 0.094 End stage"/>
 <result pre="disease 16 (15.7) 13 (21.3) 3 (7.3) 0.094 End stage" exact="renal disease" post="9 (8.8) 5 (8.2) 4 (9.8) &amp;gt;0.99 Chronic obstructive"/>
 <result pre="16 (15.7) 13 (21.3) 3 (7.3) 0.094 End stage renal" exact="disease" post="9 (8.8) 5 (8.2) 4 (9.8) &amp;gt;0.99 Chronic obstructive"/>
 <result pre="stage renal disease 9 (8.8) 5 (8.2) 4 (9.8) &amp;gt;0.99" exact="Chronic" post="obstructive pulmonary disease 8 (7.8) 7 (11.5) 1 (2.4)"/>
 <result pre="disease 9 (8.8) 5 (8.2) 4 (9.8) &amp;gt;0.99 Chronic obstructive" exact="pulmonary disease" post="8 (7.8) 7 (11.5) 1 (2.4) 0.139 Liver cirrhosis"/>
 <result pre="9 (8.8) 5 (8.2) 4 (9.8) &amp;gt;0.99 Chronic obstructive pulmonary" exact="disease" post="8 (7.8) 7 (11.5) 1 (2.4) 0.139 Liver cirrhosis"/>
 <result pre="pulmonary disease 8 (7.8) 7 (11.5) 1 (2.4) 0.139 Liver" exact="cirrhosis" post="6 (5.9) 3 (4.9) 3 (7.3) 0.682 qSOFA, median"/>
 <result pre="(95.9) 59/61 (96.7) 35/37 (94.6) - Positive of throat influenza" exact="viral" post="culture 37/95 (38.9) 23/59 (39) 14/36 (38.9) - Influenza"/>
 <result pre="&amp;gt;0.99 RT-PCR, Reverse transcription-polymerase chain reaction; qSOFA, quick Sequential Organ" exact="Failure" post="Assessment. a Untypable influenza A. jcm-09-01073-t002_Table 2Table 2 Symptom/signs"/>
 <result pre="Survivors (n = 61) Nonsurvivors (n = 41) p Value" exact="Fever" post="81 (79.4) 48 (78.7) 33 (80.5) &amp;gt;0.99 Rhinorrhea 8"/>
 <result pre="(7.3) &amp;gt;0.99 Malaise 24 (23.5) 17 (27.9) 7 (17.1) 0.241" exact="Muscle" post="pain 17 (16.7) 10 (16.4) 3 (7.3) 0.233 Headache"/>
 <result pre="(7.3) 0.389 Vomiting/nausea 6 (5.9) 5 (8.2) 1 (2.4) 0.397" exact="Diarrhea" post="2 (2) 1 (1.6) 1 (2.4) &amp;gt;0.99 Abdominal pain"/>
 <result pre="(×109/L), median (range) 7.9 (0.5–178) 8.7 (2.1–27.9) 7 (0.5–178) 0.921" exact="Platelet" post="count, (×109/L), median (range) 156.5 (4–641) 156 (60–641) 158"/>
 <result pre="102) Survivors (n = 61) Nonsurvivors (n = 41) p" exact="Acute" post="respiratory failure 99 (97) 58 (95.1) 41 (100) &amp;gt;0.99"/>
 <result pre="Survivors (n = 61) Nonsurvivors (n = 41) p Acute" exact="respiratory" post="failure 99 (97) 58 (95.1) 41 (100) &amp;gt;0.99 Time"/>
 <result pre="58 (95.1) 41 (100) &amp;gt;0.99 Time from onset illness to" exact="respiratory" post="failure, day, median (range) 4 (1–27) (n = 99)"/>
 <result pre="= 58) 4 (1–27) 0.451 Time from hospital presentation to" exact="respiratory" post="failure, day, median (range) 1 (1–21) (n = 99)"/>
 <result pre="(3–60) (n = 52) 9.5 (1–46) (n = 38) 0.042" exact="Acute" post="kidney injury 67 (65.7) 34 (55.7) 33 (80.5) 0.011"/>
 <result pre="(n = 52) 9.5 (1–46) (n = 38) 0.042 Acute" exact="kidney injury" post="67 (65.7) 34 (55.7) 33 (80.5) 0.011 Renal replacement"/>
 <result pre="Acute kidney injury 67 (65.7) 34 (55.7) 33 (80.5) 0.011" exact="Renal" post="replacement therapy 25 (24.5) 11 (18) 14 (34.1) 0.099"/>
 <result pre="Renal replacement therapy 25 (24.5) 11 (18) 14 (34.1) 0.099" exact="Pneumothorax" post="13 (12.7) 4 (6.6) 9 (22) 0.033 Acute respiratory"/>
 <result pre="(34.1) 0.099 Pneumothorax 13 (12.7) 4 (6.6) 9 (22) 0.033" exact="Acute respiratory distress syndrome" post="52 (51) 25 (41) 27 (65.9) 0.016 Pneumonia 96"/>
 <result pre="0.099 Pneumothorax 13 (12.7) 4 (6.6) 9 (22) 0.033 Acute" exact="respiratory" post="distress syndrome 52 (51) 25 (41) 27 (65.9) 0.016"/>
 <result pre="13 (12.7) 4 (6.6) 9 (22) 0.033 Acute respiratory distress" exact="syndrome" post="52 (51) 25 (41) 27 (65.9) 0.016 Pneumonia 96"/>
 <result pre="respiratory distress syndrome 52 (51) 25 (41) 27 (65.9) 0.016" exact="Pneumonia" post="96 (94.1) 57 (93.4) 39 (95.1) &amp;gt;0.99 Pulmonary edema"/>
 <result pre="(65.9) 0.016 Pneumonia 96 (94.1) 57 (93.4) 39 (95.1) &amp;gt;0.99" exact="Pulmonary" post="edema 3 (2.9) 3 (4.9) 0 0.272 Meningoencephalitis 2"/>
 <result pre="(95.1) &amp;gt;0.99 Pulmonary edema 3 (2.9) 3 (4.9) 0 0.272" exact="Meningoencephalitis" post="2 (2) 1 (1.6) 1 (2.4) &amp;gt;0.99 Intracranial hemorrhage"/>
 <result pre="&amp;gt;0.99 Intracranial hemorrhage 1 (1) 0 1 (2.4) 0.402 Gastrointestinal" exact="bleeding" post="36 (35.3) 15 (24.6) 21 (51.2) 0.011 Fulminant hepatitis"/>
 <result pre="Gastrointestinal bleeding 36 (35.3) 15 (24.6) 21 (51.2) 0.011 Fulminant" exact="hepatitis" post="9 (8.8) 6 (9.8) 3 (7.3) 0.737 Rhabdomyolysis 12"/>
 <result pre="Confidence Interval p High blood lactate levels 1.041 1.019–1.064 &amp;lt;0.001" exact="Adult" post="respiratory distress syndrome 10.098 2.505–40.714 0.001 Acute kidney injury"/>
 <result pre="Interval p High blood lactate levels 1.041 1.019–1.064 &amp;lt;0.001 Adult" exact="respiratory" post="distress syndrome 10.098 2.505–40.714 0.001 Acute kidney injury 9.019"/>
 <result pre="High blood lactate levels 1.041 1.019–1.064 &amp;lt;0.001 Adult respiratory distress" exact="syndrome" post="10.098 2.505–40.714 0.001 Acute kidney injury 9.019 1.804–45.089 0.007"/>
 <result pre="1.041 1.019–1.064 &amp;lt;0.001 Adult respiratory distress syndrome 10.098 2.505–40.714 0.001" exact="Acute" post="kidney injury 9.019 1.804–45.089 0.007 Gastrointestinal bleeding 3.828 1.180–12.415"/>
 <result pre="1.019–1.064 &amp;lt;0.001 Adult respiratory distress syndrome 10.098 2.505–40.714 0.001 Acute" exact="kidney injury" post="9.019 1.804–45.089 0.007 Gastrointestinal bleeding 3.828 1.180–12.415 0.025"/>
 <result pre="10.098 2.505–40.714 0.001 Acute kidney injury 9.019 1.804–45.089 0.007 Gastrointestinal" exact="bleeding" post="3.828 1.180–12.415 0.025"/>
</results>
